Denifanstat
地尼法司他
Report date: 2026/05/14 20:00:28
NME
Base Information
Drug NameDenifanstat
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[11]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesSagimet Biosciences Inc
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesAscletis Pharma (China) Co LtdAscletis Pharma IncWeill Medical College of Cornell University +[5]
Active Indications +[6]
Inactive Indications +[5]